Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus.
Identifieur interne : 003357 ( Ncbi/Merge ); précédent : 003356; suivant : 003358Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus.
Auteurs : Francesco Di Pierro [Oman] ; Alexander Bertuccioli [Italie] ; Ilaria Cavecchia [Italie]Source :
- Minerva gastroenterologica e dietologica [ 1827-1642 ] ; 2020.
Abstract
The outbreak of SARS-CoV-2 disease (COVID-19) is currently, March 2020, affecting more than 100000 people worldwide and, according to the WHO (World Health Organization), a pandemic is shortly expected. The virus infects the lower respiratory tract and causes severe pneumonia and mortality in approximately 10% and 3-5%, respectively, of cases, mainly among the elderly and/or people affected by other diseases. AHCC is an α-glucan-based standardized mushroom extract that has been extensively investigated as an immunostimulant both in animals and/or in humans affected by West Nile virus, influenza virus, avian influenza virus, hepatitis C virus, papillomavirus, herpes virus, hepatitis B virus and HIV by promoting a regulated and protective immune response. Although the efficacy of AHCC has not yet been specifically evaluated with respect to SARS-CoV-2 disease, its action in promoting a protective response to a wide range of viral infections, and the current absence of effective vaccines, could support its use in the prevention of diseases provoked by human pathogenic coronavirus, including COVID-19.
DOI: 10.23736/S1121-421X.20.02697-5
PubMed: 32162896
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000645
- to stream PubMed, to step Curation: 000645
- to stream PubMed, to step Checkpoint: 000330
Links to Exploration step
pubmed:32162896Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus.</title>
<author><name sortKey="Di Pierro, Francesco" sort="Di Pierro, Francesco" uniqKey="Di Pierro F" first="Francesco" last="Di Pierro">Francesco Di Pierro</name>
<affiliation wicri:level="3"><nlm:affiliation>Scientific & Research Department, Velleja Research, Milan, Italy - f.dipierro@vellejaresearch.com.</nlm:affiliation>
<country wicri:rule="url">Oman</country>
<wicri:regionArea>Scientific & Research Department, Velleja Research, Milan</wicri:regionArea>
<placeName><settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bertuccioli, Alexander" sort="Bertuccioli, Alexander" uniqKey="Bertuccioli A" first="Alexander" last="Bertuccioli">Alexander Bertuccioli</name>
<affiliation wicri:level="1"><nlm:affiliation>D.I.S.B., Urbino, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>D.I.S.B., Urbino</wicri:regionArea>
<wicri:noRegion>Urbino</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cavecchia, Ilaria" sort="Cavecchia, Ilaria" uniqKey="Cavecchia I" first="Ilaria" last="Cavecchia">Ilaria Cavecchia</name>
<affiliation wicri:level="3"><nlm:affiliation>Scientific & Research Department, Velleja Research, Milan, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Scientific & Research Department, Velleja Research, Milan</wicri:regionArea>
<placeName><settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32162896</idno>
<idno type="pmid">32162896</idno>
<idno type="doi">10.23736/S1121-421X.20.02697-5</idno>
<idno type="wicri:Area/PubMed/Corpus">000645</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000645</idno>
<idno type="wicri:Area/PubMed/Curation">000645</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000645</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000330</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000330</idno>
<idno type="wicri:Area/Ncbi/Merge">003357</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus.</title>
<author><name sortKey="Di Pierro, Francesco" sort="Di Pierro, Francesco" uniqKey="Di Pierro F" first="Francesco" last="Di Pierro">Francesco Di Pierro</name>
<affiliation wicri:level="3"><nlm:affiliation>Scientific & Research Department, Velleja Research, Milan, Italy - f.dipierro@vellejaresearch.com.</nlm:affiliation>
<country wicri:rule="url">Oman</country>
<wicri:regionArea>Scientific & Research Department, Velleja Research, Milan</wicri:regionArea>
<placeName><settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bertuccioli, Alexander" sort="Bertuccioli, Alexander" uniqKey="Bertuccioli A" first="Alexander" last="Bertuccioli">Alexander Bertuccioli</name>
<affiliation wicri:level="1"><nlm:affiliation>D.I.S.B., Urbino, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>D.I.S.B., Urbino</wicri:regionArea>
<wicri:noRegion>Urbino</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cavecchia, Ilaria" sort="Cavecchia, Ilaria" uniqKey="Cavecchia I" first="Ilaria" last="Cavecchia">Ilaria Cavecchia</name>
<affiliation wicri:level="3"><nlm:affiliation>Scientific & Research Department, Velleja Research, Milan, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Scientific & Research Department, Velleja Research, Milan</wicri:regionArea>
<placeName><settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Minerva gastroenterologica e dietologica</title>
<idno type="eISSN">1827-1642</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The outbreak of SARS-CoV-2 disease (COVID-19) is currently, March 2020, affecting more than 100000 people worldwide and, according to the WHO (World Health Organization), a pandemic is shortly expected. The virus infects the lower respiratory tract and causes severe pneumonia and mortality in approximately 10% and 3-5%, respectively, of cases, mainly among the elderly and/or people affected by other diseases. AHCC is an α-glucan-based standardized mushroom extract that has been extensively investigated as an immunostimulant both in animals and/or in humans affected by West Nile virus, influenza virus, avian influenza virus, hepatitis C virus, papillomavirus, herpes virus, hepatitis B virus and HIV by promoting a regulated and protective immune response. Although the efficacy of AHCC has not yet been specifically evaluated with respect to SARS-CoV-2 disease, its action in promoting a protective response to a wide range of viral infections, and the current absence of effective vaccines, could support its use in the prevention of diseases provoked by human pathogenic coronavirus, including COVID-19.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32162896</PMID>
<DateRevised><Year>2020</Year>
<Month>03</Month>
<Day>12</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1827-1642</ISSN>
<JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year>
<Month>Mar</Month>
<Day>12</Day>
</PubDate>
</JournalIssue>
<Title>Minerva gastroenterologica e dietologica</Title>
<ISOAbbreviation>Minerva Gastroenterol Dietol</ISOAbbreviation>
</Journal>
<ArticleTitle>Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus.</ArticleTitle>
<ELocationID EIdType="doi" ValidYN="Y">10.23736/S1121-421X.20.02697-5</ELocationID>
<Abstract><AbstractText>The outbreak of SARS-CoV-2 disease (COVID-19) is currently, March 2020, affecting more than 100000 people worldwide and, according to the WHO (World Health Organization), a pandemic is shortly expected. The virus infects the lower respiratory tract and causes severe pneumonia and mortality in approximately 10% and 3-5%, respectively, of cases, mainly among the elderly and/or people affected by other diseases. AHCC is an α-glucan-based standardized mushroom extract that has been extensively investigated as an immunostimulant both in animals and/or in humans affected by West Nile virus, influenza virus, avian influenza virus, hepatitis C virus, papillomavirus, herpes virus, hepatitis B virus and HIV by promoting a regulated and protective immune response. Although the efficacy of AHCC has not yet been specifically evaluated with respect to SARS-CoV-2 disease, its action in promoting a protective response to a wide range of viral infections, and the current absence of effective vaccines, could support its use in the prevention of diseases provoked by human pathogenic coronavirus, including COVID-19.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Di Pierro</LastName>
<ForeName>Francesco</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Scientific & Research Department, Velleja Research, Milan, Italy - f.dipierro@vellejaresearch.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bertuccioli</LastName>
<ForeName>Alexander</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>D.I.S.B., Urbino, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cavecchia</LastName>
<ForeName>Ilaria</ForeName>
<Initials>I</Initials>
<AffiliationInfo><Affiliation>Scientific & Research Department, Velleja Research, Milan, Italy.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>03</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Italy</Country>
<MedlineTA>Minerva Gastroenterol Dietol</MedlineTA>
<NlmUniqueID>9109791</NlmUniqueID>
<ISSNLinking>1121-421X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>3</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>3</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>3</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32162896</ArticleId>
<ArticleId IdType="pii">S1121-421X.20.02697-5</ArticleId>
<ArticleId IdType="doi">10.23736/S1121-421X.20.02697-5</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Italie</li>
<li>Oman</li>
</country>
<region><li>Lombardie</li>
</region>
<settlement><li>Milan</li>
</settlement>
</list>
<tree><country name="Oman"><region name="Lombardie"><name sortKey="Di Pierro, Francesco" sort="Di Pierro, Francesco" uniqKey="Di Pierro F" first="Francesco" last="Di Pierro">Francesco Di Pierro</name>
</region>
</country>
<country name="Italie"><noRegion><name sortKey="Bertuccioli, Alexander" sort="Bertuccioli, Alexander" uniqKey="Bertuccioli A" first="Alexander" last="Bertuccioli">Alexander Bertuccioli</name>
</noRegion>
<name sortKey="Cavecchia, Ilaria" sort="Cavecchia, Ilaria" uniqKey="Cavecchia I" first="Ilaria" last="Cavecchia">Ilaria Cavecchia</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003357 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 003357 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Ncbi |étape= Merge |type= RBID |clé= pubmed:32162896 |texte= Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:32162896" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |